INC Research enters India; PPD expands reach

By Kirsty Barnes

- Last updated on GMT

Related tags: Contract research organization, Clinical trial

INC Research has become the latest contract research organisation
(CRO) to dive into India, whilst Pharmaceutical Products
Development (PPD) has opened offices in Athens and Seattle.

The move into India was facilitated for INC Research through an equal joint venture relationship that the US-based CRO has formed with Indian firm GVK Biosciences, called INC GVK BIO. "This partnership enables both companies to further expand their global reach and supports our growth plan into areas of clinical demand by our customers,"​ said Jim Ogle, CEO of INC Research. "Our customers have repeatedly indicated a strong interest in our having a solid operational presence in India,"​ added Kelvin Logan, president of INC Research Europe. Under the new arrangement, the firms will be running Phase I-IV clinical trials from dedicated GVK facilities in the Indian cities of Hyderabad, Chennai and Gurgaon, Delhi. Meanwhile, larger rival PPD said it has answered the call for a broader geographic presence by opening two new offices in Athens, Greece, and Seattle, US. Both offices will now serve as hubs for the PPD employees who were previously operating in these areas on a regional basis, providing development services for Phase II-IV studies. The office in Athens focuses on patient recruitment, clinical monitoring and regulatory support while the Seattle office houses clinical monitoring and project management teams. "The new offices enable us to address the organic growth of our business driven by client needs for Phase II-IV services as well as enhance support for our employees located in these areas,"​ said Fred Eshelman, CEO of PPD. "We plan continued investment in infrastructure, systems and people to align with the global research needs of our clients." ​ In other related news, PharmaNet is planning to lease a new 50,000 sq. ft office space in Cary, North Carolina, in order to consolidate its operations that are currently running nearby in Cary as well as in Morrrisville. The move, which will involve over 100 employees, is expected to take place after construction is completed in the second quarter of 2008.

Related news

Show more

Related products

show more

Strategic Approach to Immunogenicity Assessment

Strategic Approach to Immunogenicity Assessment

Altasciences | 17-May-2022 | Technical / White Paper

In this issue of The Altascientist we provide a detailed overview on the different goals and challenges that are presented by the validation of immunogenicity...

Governing and Maintaining Clinical Data Standards

Governing and Maintaining Clinical Data Standards

Veeva | 10-May-2022 | Technical / White Paper

Investing in data standards plays a huge role in improving the quality of clinical studies. But often, people don’t use the standards correctly, there...

What the Best Clinical Study Build Pros Do

What the Best Clinical Study Build Pros Do

Formedix | 09-May-2022 | Technical / White Paper

Getting your clinical study designed and built ready for data collection takes A LOT of work and expertise… you've got to do all your CRF designs;...

What should a clinical metadata repository do?

What should a clinical metadata repository do?

Formedix | 18-Apr-2022 | Technical / White Paper

Choosing a clinical metadata repository (MDR) software can be a tough task as the capabilities and features of your chosen MDR could make or break your...

Related suppliers

Follow us


View more